Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
회사 코드RGC
회사 이름Regencell Bioscience Holdings Ltd
상장일Jul 16, 2021
설립일2014
CEO- -
직원 수12
유형Ordinary Share
회계 연도 종료Jul 16
주소11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
도시
증권 거래소NASDAQ Capital Market Consolidated
국가Hong Kong
우편 번호- -
전화85221550823
웹사이트https://www.regencellbioscience.com/
회사 코드RGC
상장일Jul 16, 2021
설립일2014
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음